Black Wo(Men) Speak Symposium 2022
Click for an overview of information from the symposium highlighting the need for increased diversity in clinical trials.
FDA Approves Orserdu and Expands Approval of Trodelvy®
Read about the clinical trials that contributed to 2 recent approvals of MBC treatment options.
New ESR1 Biomarker Research Leads to FDA Approval for ER+, HER2- MBC with an ESR1 Mutation
Click to learn about elacestrant (Orserdu) as well as the Guardant360 blood test that identifies people likely to benefit from the drug.
What is Stable Disease and How is it Monitored?
Read about stable disease and current research on monitoring MBC treatment response.
Assembling a Healthcare Team That Hears and Respects You
Your voice is important in making decisions about your care, which may include clinical trials. Learn more here about assembling your healthcare team and the importance of your voice in decision-making.
Clinical Trial Participation: The Patient’s Journey
Participating in a clinical trial is a process with many steps. Learn more about what to expect during each step of your clinical trial journey.
Metastatic Trial Search Featured in Clinical Trials Webinar
Watch this video for an overview of breast cancer clinical trials, the importance of diversity in trials, as well as a demonstration of Metastatic Trial Search.
Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
In part 3 of a 3-part series, learn about biomarkers that require more research before being recommended to guide treatment decisions.
I Found a Trial I’m Interested In. What’s Next?
If you are interested in joining a clinical trial, read about steps to take and questions to ask your doctor and research team.
Does My Health Insurance Cover the Costs of Participating in a Clinical Trial?
How are costs covered by different types of insurance? What costs are covered by the clinical trial team? What if insurance denies a trial-related claim? Get answers and support here.